—HUM
— • —
$192.15
P/E
19.59
PEG
—
FCF Yield
—
Rev Growth YoY
+1011.0% YoY
Gross Margin
—
Health Score
4/10
D/E Ratio
0.70
Confidence
LOW
Business Snapshot
The ticker and exchange data provided are incomplete, which limits full company identification. Based on the available financial profile — a current price of $192.15, a Price/Sales ratio of 0.18x, a net margin of 92.0%, and revenue growth of 1,011% year-over-year — this appears to be a company operating in a high-margin, likely financial or royalty-based business. Without a confirmed market cap figure, cap-tier classification cannot be assigned with certainty.
Financial Health
**Score: 4/10** The financial picture is deeply conflicted. On the positive side, the net margin of 92.0% is exceptional by any standard, and a debt/equity ratio of 0.7x is manageable...
Risk Assessment
- **LIQUIDITY:** Current ratio of 0.01x is critically low, indicating near-total inability to cover short-term liabilities with current assets. - **EARNINGS DETERIORATION:** Earnings growth of -151% year-over-year means the company moved deeper into loss territory despite 1,011% revenue growth — a margin compression or cost escalation warning. - **VALUATION DISCONNECT:** EV/EBITDA of 83.97x is extremely high and conflicts sharply with the low P/S of 0.18x, suggesting significant distortion in reported financials. - **DATA TRANSPARENCY:** TTM Revenue, TTM Net Income, Free Cash Flow, gross margin, and market cap are all unavailable — making comprehensive fundamental analysis impossible. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) and a bearish MACD signal indicate sustained negative price momentum. ---...